A Study of Efficacy and Safety of Mongersen (GED-0301) for the Treatment of Adult and Adolescent Subjects With Active Crohn's Disease
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Denesh Chitkara, MD
Celgene Corporation
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
311 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Royal Prince Alfred Hospital
Camperdown, New South Wales, Australia
- Concord Repatriation General Hospital
Concord, New South Wales, Australia
- Centre for Digestive Diseases
Five Dock, New South Wales, Australia
- Liverpool Hospital
Liverpool, New South Wales, Australia
- Royal Brisbane and Women'S Hospital
Herston, Queensland, Australia
- Mater Adult Hospital
South Brisbane, Queensland, Australia
- Princess Alexandra Hospital
Woolloongabba, Queensland, Australia
- Royal Adelaide Hospital Institute of Medical and Veterinary Science
Adelaide, South Australia, Australia
- Box Hill Hospital
Box Hill, Victoria, Australia
- the Alfred Hospital
Melbourne, Victoria, Australia
- Fiona Stanley Hospital
Murdoch, Western Australia, Australia
- Ballarat Base Hospital
Ballarat, Australia
- Monash Medical Centre Clayton
Bentleigh East, Australia
- St Vincents Hospital Melbourne
Fitzroy, Australia
- Klinikum Klagenfurt Am Wörtersee
Klagenfurt, Austria
- Lkh - Universitätsklinikum Der Pmu Salzburg
Salzburg, Austria
- Krankenanstalt Rudolfstiftung Wien
Wein, Austria
- Cliniques Universitaires Saint-Luc
Brussels, Belgium
- Hopital Universitaire Des Enfants
Brussels, Belgium
- Uz Antwerpen
Edegem, Belgium
- Universitair Ziekenhuis Gent
Ghent, Belgium
- Chu Sart Tilman
Liège, Belgium
- Alberta Childrens Hospital
Calgary, Alberta, Canada
- Gi Research Institute
Vancouver, British Columbia, Canada
- Barrie Gi Associates
Barrie, Ontario, Canada
- Lhsc - Victoria Hospital
London, Ontario, Canada
- Mount Sinai Hospital
Toronto, Ontario, Canada
- the Hospital for Sick Children
Toronto, Ontario, Canada
- Centre de Sante Et de Services Sociaux Champlain Charles Le Moyne
Greenfield Park, Quebec, Canada
- Royal University Hospital
Saskatoon, Saskatchewan, Canada
- Clinical Hospital Centre Osijek
Osijek, Croatia
- Hepato-Gastroenterologie Hk, S. R. O.
Hradec Králové, Czechia
- Preventamed
Olomouc, Czechia
- Ccbr Prague Cz
Prague, Czechia
- Thomayerova Nemocnice
Prague, Czechia
- Aarhus Universitetshospital
Aahus C, Denmark
- Alborg Universitets Hospital
Aalborg, Denmark
- Hvidovre Hospital
Hvidovre, Denmark
- Koge Sygehus
Køge, Denmark
- Odense Universitetshospital
Odense C, Denmark
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 Dec 2017
- Primary completion
- 17 Nov 2018
- Completion
- 24 Dec 2018
- Last update posted
- 14 Nov 2017
- Registered enrollment
- 0
- Registry id
- NCT02974322
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.